Comment on "Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial": The RAPIDO Trial Does Not Achieve Its Primary Endpoint.

Annals of surgery open : perspectives of surgical history, education, and clinical approaches 2023 Jun 02

Comment on "Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial": The RAPIDO Trial Does Not Achieve Its Primary Endpoint.

Related Questions

How would you manage a patient with synchronous locally advanced rectal adenocarcinoma (T3N2) and a large T2N0 adenocarcinoma of mid and distal esophagus?

New answer by Medical Oncologist at Charles A. Sammons Cancer Center at Baylor University Medical Center (October 6, 2023)

It's tempting to try to squeeze chemoradiotherapy when we have 2 tumor areas but it will be too complex for likely marginal advantage.Few things to keep in mind: We make sure...

Read more (3 Answers available)